Clinical Trials

Showing trials with last updates posted in 2025.

NCT06750536 | RECRUITING
20 Participants

Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-10-12
Completion: 2026-10-31
Conditions
Extracorporeal Membrane Oxygenation Complication Neonatal Aspiration Pneumonia Acute Respiratory Failure Acute Lung Injury
Interventions
DEVICE
No Results Yet
NCT06750432 | ACTIVE_NOT_RECRUITING | PHASE1
144 Participants

PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-12-13
Completion: 2026-12-31
Conditions
Alzheimer Disease, Early Onset
Interventions
DRUG
No Results Yet
NCT06747117 | RECRUITING
300 Participants

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigoâ„¢ Aspiration System (STRIDE II)

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-18
Completion: 2028-06-30
Conditions
Lower Extremity Acute Limb Ischemia LE ALI
Interventions
DEVICE
No Results Yet
NCT06736899 | RECRUITING | NA
200 Participants

Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-10-23
Completion: 2025-12-31
Conditions
Coronary Artery Disease Coronary Disease
Interventions
DEVICE
No Results Yet
NCT06736600 | RECRUITING | NA
45 Participants

Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-18
Completion: 2027-08-31
Conditions
Peripheral Neuropathy Due to Chemotherapy
Interventions
BEHAVIORAL
No Results Yet
NCT06735534 | RECRUITING | NA
407 Participants

Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-06-03
Completion: 2027-04-30
Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE
No Results Yet
NCT06730126 | RECRUITING | PHASE2
15 Participants

Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-10
Completion: 2026-03-01
Conditions
Autoimmune Lymphoproliferative Syndrome
Interventions
DRUG
No Results Yet
NCT06727565 | RECRUITING | PHASE2
100 Participants

Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-18
Completion: 2026-08-31
Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG
No Results Yet
NCT06726174 | ENROLLING_BY_INVITATION | PHASE1
12 Participants

Cell Therapy for Corneal Endothelial Cell Dysfunction

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-25
Completion: 2028-12-31
Conditions
Corneal Endothelial Cell Dysfunction
Interventions
DRUG
No Results Yet
NCT06722183 | RECRUITING | PHASE2
33 Participants

Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-12-16
Completion: 2028-03-31
Conditions
Colorectal Cancer
Interventions
DRUG
No Results Yet
NCT06722157 | ACTIVE_NOT_RECRUITING | PHASE2
202 Participants

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-01-06
Completion: 2026-10-16
Conditions
Macular Degeneration, Age-related Geographic Atrophy
Interventions
DRUG
No Results Yet
NCT06721156 | RECRUITING | PHASE2
350 Participants

A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-12-16
Completion: 2026-12-31
Conditions
Alzheimer Disease Dementia
Interventions
DRUG
No Results Yet
NCT06717347 | RECRUITING | PHASE3
1046 Participants
NCT06699108 | ACTIVE_NOT_RECRUITING | PHASE3
45 Participants

Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-12-13
Completion: 2026-12-01
Conditions
Bietti Crystalline Dystrophy Inherited Retinal Diseases
Interventions
DRUG
No Results Yet
NCT06698926 | ACTIVE_NOT_RECRUITING | PHASE1
110 Participants

A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-11-11
Completion: 2026-01-08
Conditions
Healthy Volunteer
Interventions
DRUG
No Results Yet
NCT06692881 | RECRUITING
167 Participants

Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-12
Completion: 2026-01-31
Conditions
Migraine
No Results Yet
NCT06692738 | RECRUITING | PHASE3
880 Participants

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-11-18
Completion: 2029-02-05
Conditions
Non-small Cell Lung Cancer
Interventions
DRUG
No Results Yet
NCT06692192 | RECRUITING | PHASE1
60 Participants

The RECAP2 Study: Midazolam and Psilocybin

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-08-07
Completion: 2027-12-31
Conditions
Psilocybin
Interventions
DRUG
No Results Yet
NCT06686394 | RECRUITING | PHASE1/PHASE2
81 Participants

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-26
Completion: 2030-04-18
Conditions
Breast Neoplasms Breast Cancer
Interventions
BIOLOGICAL
No Results Yet
NCT06685757 | RECRUITING | PHASE3
120 Participants

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-12-03
Completion: 2026-12-01
Conditions
Antibody-mediated Rejection
Interventions
DRUG
No Results Yet
NCT06683898 | COMPLETED | NA
50 Participants

The Role of Focus Strategies on Pilates

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-10-05
Completion: 2025-04-15
Conditions
Reaction Time Humans Exercise Therapy Exercise Movement Techniques Pilates
Interventions
OTHER
No Results Yet
NCT06682988 | RECRUITING | PHASE2
110 Participants

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-28
Completion: 2028-03-31
Conditions
Advanced High-Grade Epithelial Ovarian Primary Peritoneal Fallopian Tube Cancers High Folate Receptor-Alpha Expression Platinum Resistant
Interventions
DRUG
No Results Yet
NCT06681103 | COMPLETED | NA
1112 Participants

Intention to Change and Treatment-Seeking in Pathological Gamblers and Investors: An Experimental Study in Young Adults

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-12-20
Completion: 2025-06-30
Conditions
Gambling Disorder
Interventions
BEHAVIORAL
No Results Yet
NCT06680388 | RECRUITING | EARLY_PHASE1
15 Participants

CD19 CAR-T in the Treatment of Relapsed/Refractory Autoimmune Diseases

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-11-15
Completion: 2027-12-31
Conditions
Autoimmune Diseases
Interventions
DRUG
No Results Yet
NCT06678841 | RECRUITING | NA
700 Participants

ELEVATE-HFpEF Clinical Study

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-07-09
Completion: 2028-08-31
Conditions
Heart Failure With Preserved Ejection Fraction (HFpEF)
Interventions
DEVICE
No Results Yet
NCT06667700 | RECRUITING | PHASE3
3082 Participants

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-12-02
Completion: 2031-01-26
Conditions
Coronavirus Disease (COVID-19)
Interventions
DRUG
No Results Yet
NCT06666192 | RECRUITING | NA
2067 Participants

The Ohio State University (OSU) SCREEN Community Program

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-03-12
Completion: 2029-12-31
Conditions
Breast Carcinoma Cervical Carcinoma Colorectal Carcinoma
Interventions
OTHER BEHAVIORAL PROCEDURE
No Results Yet
NCT06663319 | RECRUITING | PHASE1
170 Participants

A Study of JNJ-89402638 for Metastatic Colorectal Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-10-15
Completion: 2028-02-25
Conditions
Unresectable Metastatic Colorectal Cancer
Interventions
DRUG
No Results Yet
NCT06660563 | ACTIVE_NOT_RECRUITING | PHASE1
19 Participants

A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-10-22
Completion: 2026-01-19
Conditions
Lymphoma, Non-Hodgkin
Interventions
DRUG
No Results Yet
NCT06658197 | NOT_YET_RECRUITING | PHASE3
850 Participants

Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-12-02
Completion: 2026-12-01
Conditions
Stroke, Ischemic Stroke, Acute Thrombosis, Brain Drug Effect
Interventions
DRUG
No Results Yet
NCT06651632 | RECRUITING | NA
280 Participants

WATER IV Prostate Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-03
Completion: 2027-07-31
Conditions
Localized Prostate Cancer
Interventions
DEVICE PROCEDURE
No Results Yet
NCT06640283 | RECRUITING | PHASE2
150 Participants

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-14
Completion: 2026-12-31
Conditions
HPV-Related Carcinoma Uterine Cervical Cancer Anal Canal Cancer HPV-Related Anal Squamous Cell Carcinoma HPV-Related Cervical Carcinoma
Interventions
DIAGNOSTIC_TEST DRUG
No Results Yet
NCT06636032 | RECRUITING | PHASE1/PHASE2
9 Participants

Dose Escalation of Allogeneic Adipose Derived Stroma/Stem Cells for the Treatment of Crohn's Fistula

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-12
Completion: 2027-09-30
Conditions
Crohn Disease
Interventions
DRUG
No Results Yet
NCT06626256 | WITHDRAWN | PHASE1
0 Participants

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-12-05
Completion: 2027-10-30
Conditions
Locally Advanced Cervical Carcinoma Locally Advanced Colorectal Carcinoma Locally Advanced Malignant Solid Neoplasm Locally Advanced Melanoma Locally Advanced Pancreatic Ductal Adenocarcinoma Locally Advanced Renal Cell Carcinoma Metastatic Cervical Carcinoma Metastatic Colorectal Carcinoma Metastatic Malignant Solid Neoplasm Metastatic Melanoma Metastatic Pancreatic Ductal Adenocarcinoma Metastatic Renal Cell Carcinoma Stage II Pancreatic Cancer AJCC v8 Stage III Cervical Cancer AJCC v8 Stage III Colorectal Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage III Renal Cell Cancer AJCC v8 Stage IV Cervical Cancer AJCC v8 Stage IV Colorectal Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8 Unresectable Cervical Carcinoma Unresectable Colorectal Carcinoma Unresectable Malignant Solid Neoplasm Unresectable Melanoma Unresectable Pancreatic Ductal Adenocarcinoma Unresectable Renal Cell Carcinoma
Interventions
BIOLOGICAL PROCEDURE DRUG
No Results Yet
NCT06623422 | RECRUITING | PHASE3
680 Participants

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-10-21
Completion: 2033-05-16
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
BIOLOGICAL DRUG OTHER
No Results Yet
NCT06618287 | RECRUITING | PHASE1/PHASE2
416 Participants

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-04
Completion: 2031-02-26
Conditions
Lung Cancer Breast Cancer
Interventions
DRUG
No Results Yet
NCT06616623 | SUSPENDED | PHASE1
24 Participants

Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-12-31
Completion: 2026-12-31
Conditions
Metastatic Lung Non-Small Cell Carcinoma Recurrent Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8
Interventions
BIOLOGICAL PROCEDURE DRUG
No Results Yet
NCT06613516 | WITHDRAWN | PHASE2
0 Participants

Effect of Capivasertib on ctDNA in ER Positive Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-01
Completion: 2025-09-16
Conditions
Breast Cancer Oestrogen Receptor Positive Breast Cancer
Interventions
DRUG
No Results Yet
NCT06612827 | RECRUITING
20 Participants

Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-05
Completion: 2028-12-15
Conditions
Undifferentiated Carcinoma
Interventions
OTHER
No Results Yet
NCT06610838 | RECRUITING
600 Participants

Effects of E-cigarette Use on Health

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-01-06
Completion: 2029-06-30
Conditions
Electronic Cigarette Use
Interventions
OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page